Jason Rickard - 14 Dec 2022 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role: SVP, Chief Operating Officer
Signature: /s/ Brian Tessler, Attorney-in-Fact
Issuer symbol: IRWD
Transactions as of: 14 Dec 2022
Net transactions value: -$334,530
Form type: 4
Filing time: 16 Dec 2022, 15:05:38 UTC
Previous filing: 17 Aug 2022
Next filing: 19 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRWD	Class A Common Stock	Sale	$334,530	-27,000	-7.2%	$12.39	348,736	14 Dec 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.38 to $12.41,inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.38 to $12.41,inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.